
Novel селективный bromodomain and extra-terminal domain (BET) protein family ингибитор (BETi ), inducing an ‘activated’ keratinocyte transcriptional profile with reversal of chronic wound biomarkers in human skin ex vivo
Novel selective bromodomain and extra-terminal domain (BET) protein family inhibitor (BETi ), inducing an ‘activated’ keratinocyte transcriptional profile with reversal of chronic wound biomarkers in human skin ex vivo
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.